Our study included more patients (n = 649) and serial measurements over 5 years of disease, analyzed with a repeated measurement analysis that can take all measured data into account independent of whether there are some missing values over time, which all increased the power of the current study and enabled well-powered studies within ACPA-positive and ACPA-negative RA separately. Here, PRTN3 is linked to rheumatoid arthritis.